This inventor holds 1 USPTO granted patent. Top assignees: Micropharm Limited, Oxford University Innovation Ltd, The Secretary of State for Health. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 484 
1 out of 28 Years Active: 2019
Title: Thomas Bowden - Innovator in Filovirus Therapy
Introduction
Thomas Bowden is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical science, particularly in the treatment of viral diseases. His work focuses on developing therapies that can combat serious health threats.
Latest Patents
Thomas Bowden holds a patent for a groundbreaking invention related to Filovirus therapy. This patent provides antibodies that are used in the treatment, suppression, and prevention of Filovirus diseases, particularly Ebola virus disease. Additionally, the patent includes immunogens that are designed to elicit such antibodies, showcasing his innovative approach to tackling viral infections.
Career Highlights
Throughout his career, Thomas has worked with various organizations, including the Secretary of State for Health and Micropharm Limited. His experience in these roles has allowed him to contribute to important health initiatives and research projects.
Collaborations
Thomas has collaborated with notable professionals in his field, including Miles Carroll and Stuart Dowall. These partnerships have enhanced his research and development efforts, leading to advancements in Filovirus therapy.
Conclusion
Thomas Bowden's work in Filovirus therapy exemplifies his commitment to improving public health through innovation. His contributions are vital in the ongoing fight against viral diseases, particularly those as severe as Ebola.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile